MANILA, Nov 17 (Reuters) – Philippine President Rodrigo Duterte has declared a state of emergency in the The Philippines has approved the emergency use of a COVID-19 vaccine by Novavax Inc (NVAX.O), its food and drug administration chairman said on Wednesday, making it the Southeast Asian country’s eighth vaccine approval.
The nanoparticle vaccine, known as Covovax, will be developed by Serum Institute of India and is licenced for use on individuals 18 and older, according to the agency’s chief Rolando Enrique Domingo during a press conference.
Covovax, which had efficacy of 89.7% in clinical trials, will be administered in two doses not less than 21 days apart, Domingo added.
The Philippines has inoculated more than a quarter of its 110 million population.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…